329 related articles for article (PubMed ID: 15520856)
21. ABCA1. The gatekeeper for eliminating excess tissue cholesterol.
Oram JF; Lawn RM
J Lipid Res; 2001 Aug; 42(8):1173-9. PubMed ID: 11483617
[TBL] [Abstract][Full Text] [Related]
22. Plasma amyloid-β in patients with Tangier disease.
Shahim P; Bochem AE; Mattsson N; Lautner R; Blennow K; Hovingh GK; Motazacker MM; Zetterberg H
J Alzheimers Dis; 2013; 35(2):307-12. PubMed ID: 23388172
[TBL] [Abstract][Full Text] [Related]
23. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks.
Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
Atherosclerosis; 2005 Dec; 183(2):199-212. PubMed ID: 15935359
[TBL] [Abstract][Full Text] [Related]
24. Study of ABCA1 function in transgenic mice.
Joyce C; Freeman L; Brewer HB; Santamarina-Fojo S
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):965-71. PubMed ID: 12615681
[TBL] [Abstract][Full Text] [Related]
25. A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
Maranghi M; Truglio G; Gallo A; Grieco E; Verrienti A; Montali A; Gallo P; Alesini F; Arca M; Lucarelli M
Biochem Biophys Res Commun; 2019 Jan; 508(2):487-493. PubMed ID: 30503498
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease.
Negi SI; Brautbar A; Virani SS; Anand A; Polisecki E; Asztalos BF; Ballantyne CM; Schaefer EJ; Jones PH
J Clin Lipidol; 2013; 7(1):82-7. PubMed ID: 23351586
[TBL] [Abstract][Full Text] [Related]
27. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population.
Frikke-Schmidt R
Atherosclerosis; 2010 Feb; 208(2):305-16. PubMed ID: 19596329
[TBL] [Abstract][Full Text] [Related]
28. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux.
Wang N; Tall AR
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1178-84. PubMed ID: 12738681
[TBL] [Abstract][Full Text] [Related]
29. Association of HDL deficiency with a novel mutation in the ABCA1 gene.
Denk GU; Aslanidis C; Schmitz G; Parhofer KG; Pusl T
Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):53-5. PubMed ID: 20533173
[TBL] [Abstract][Full Text] [Related]
30. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation.
Aiello RJ; Brees D; Francone OL
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):972-80. PubMed ID: 12615679
[TBL] [Abstract][Full Text] [Related]
31. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
[TBL] [Abstract][Full Text] [Related]
32. Novel polypyrimidine variation (IVS46: del T -39...-46) in ABCA1 causes exon skipping and contributes to HDL cholesterol deficiency in a family with premature coronary disease.
Hong SH; Rhyne J; Miller M
Circ Res; 2003 Nov; 93(10):1006-12. PubMed ID: 14576201
[TBL] [Abstract][Full Text] [Related]
33. ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.
Srivastava N
Mol Cell Biochem; 2002 Aug; 237(1-2):155-64. PubMed ID: 12236582
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.
Marcil M; Brooks-Wilson A; Clee SM; Roomp K; Zhang LH; Yu L; Collins JA; van Dam M; Molhuizen HO; Loubster O; Ouellette BF; Sensen CW; Fichter K; Mott S; Denis M; Boucher B; Pimstone S; Genest J; Kastelein JJ; Hayden MR
Lancet; 1999 Oct; 354(9187):1341-6. PubMed ID: 10533863
[TBL] [Abstract][Full Text] [Related]
35. ABCA1 and atherosclerosis.
Soumian S; Albrecht C; Davies AH; Gibbs RG
Vasc Med; 2005 May; 10(2):109-19. PubMed ID: 16013195
[TBL] [Abstract][Full Text] [Related]
36. Tangier disease four decades of research: a reflection of the importance of HDL.
Kolovou GD; Mikhailidis DP; Anagnostopoulou KK; Daskalopoulou SS; Cokkinos DV
Curr Med Chem; 2006; 13(7):771-82. PubMed ID: 16611066
[TBL] [Abstract][Full Text] [Related]
37. Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1.
El Khoury P; Couvert P; Elbitar S; Ghaleb Y; Abou-Khalil Y; Azar Y; Ayoub C; Superville A; Guérin M; Rabès JP; Varret M; Boileau C; Jambart S; Giral P; Carrié A; Le Goff W; Abifadel M
J Clin Lipidol; 2018; 12(6):1374-1382. PubMed ID: 30361172
[TBL] [Abstract][Full Text] [Related]
38. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.
van Dam MJ; de Groot E; Clee SM; Hovingh GK; Roelants R; Brooks-Wilson A; Zwinderman AH; Smit AJ; Smelt AH; Groen AK; Hayden MR; Kastelein JJ
Lancet; 2002 Jan; 359(9300):37-42. PubMed ID: 11809185
[TBL] [Abstract][Full Text] [Related]
39. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.
Rust S; Rosier M; Funke H; Real J; Amoura Z; Piette JC; Deleuze JF; Brewer HB; Duverger N; Denèfle P; Assmann G
Nat Genet; 1999 Aug; 22(4):352-5. PubMed ID: 10431238
[TBL] [Abstract][Full Text] [Related]
40. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders.
Pisciotta L; Hamilton-Craig I; Tarugi P; Bellocchio A; Fasano T; Alessandrini P; Bon GB; Siepi D; Mannarino E; Cattin L; Averna M; Cefalù AB; Cantafora A; Calandra S; Bertolini S
Atherosclerosis; 2004 Feb; 172(2):309-20. PubMed ID: 15019541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
